Biogen Newsroom

Wolfe Research Initiates Biogen(BIIB.US) With Hold Rating

Futu News05:32 · Ratings

Gilead, Vertex Initiated as New Big Biotech Buys at Citi

Seeking Alpha03:26

5 Healthcare Stocks to Buy in a Beaten-Up Sector -- Barrons.com

Barron's02:53

Raymond James Maintains Biogen(BIIB.US) With Hold Rating

Futu News02:32 · Ratings

Biogen's Alzheimer's Disease Drug Gets Positive Opinion From Europe Regulators

MT Newswires01:08

Biogen, Eisai Win CHMP Backing of Leqembi Alzheimer's Drug

WSJ00:59

Express News | Biogen Shares up 2.5% After EU Health Regulator Recommends Co and Eisai's Alzheimer's Drug

Breakings00:09

CHMP Recommends EU Approval For Eisai's Leqembi To Treat Early Alzheimer's Disease In Apolipoprotein E Ε4 Non-Carriers And Heterozygotes; Leqembi, A Monoclonal Antibody, Shown To Slow Cognitive Decline

Benzinga00:04

Peeling Back The Layers: Exploring Biogen Through Analyst Insights

BenzingaNov 14 23:00

Biogen Initiated at Neutral by Citigroup

Dow JonesNov 14 21:04 · Ratings

RNA Stock Hits Record High on Entering the Cardiac Disease Space

Zacks Nov 14 21:00

Citi Maintains Biogen(BIIB.US) With Hold Rating, Cuts Target Price to $190

Futu NewsNov 14 05:32 · Ratings

Express News | Citi has given biogen a neutral initial rating, with a target price of $190.

BreakingsNov 14 05:13

Here's Why Biogen Inc. (BIIB) Is a Strong Value Stock

Yahoo FinanceNov 12 22:40

Argus Cuts Biogen's Price Target to $200 From $250

MT NewswiresNov 6 03:14 · Ratings

Are Investors Undervaluing Biogen (BIIB) Right Now?

Yahoo FinanceNov 5 22:40

J.P. Morgan Maintains Biogen(BIIB.US) With Hold Rating, Cuts Target Price to $210

Futu NewsNov 5 03:31 · Ratings

JP Morgan Maintains Neutral on Biogen, Lowers Price Target to $210

BenzingaNov 4 22:37 · Ratings

Biogen Analyst Ratings

BenzingaNov 4 22:36 · Ratings

Biogen Stock Touches 52-week Low at $173.01 Amid Market Challenges

InvestingNov 4 22:32